Recruiting
Phase 1

Ruxolitinib & T-Regs

Sponsor:

Cellenkos, Inc.

Code:

NCT05423691

Conditions

Myelofibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CK0804

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Cellenkos, Inc. on 2025-04-13.